Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 06, 2021

SELL
$2.36 - $3.2 $10,320 - $13,993
-4,373 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$2.6 - $4.16 $6,084 - $9,734
2,340 Added 115.1%
4,373 $14,000
Q2 2019

Aug 14, 2019

BUY
$2.75 - $5.0 $5,590 - $10,165
2,033 New
2,033 $6,000

Others Institutions Holding CKPT

About Checkpoint Therapeutics, Inc.


  • Ticker CKPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 85,497,000
  • Market Cap $351M
  • Description
  • Checkpoint Therapeutics, Inc., clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to...
More about CKPT
Track This Portfolio

Track Ameritas Investment Partners, Inc. Portfolio

Follow Ameritas Investment Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.